A Prospective Randomized Controlled Multicenter Phase-III Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART 3D Plus Compared to the Standard Procedure Microfracture in the Treatment of Articular Cartilage Defects of the Knee
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2018
At a glance
- Drugs Autologous chondrocyte implant TETEC (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors TETEC
- 12 Feb 2018 Planned End Date changed from 1 Jun 2019 to 1 May 2021.
- 12 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Jan 2018 New trial record